- Home
- DNLI vs KEN Comparison
DNLI vs KEN Comparison
Compare DNLI & KEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNLI | KEN |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.6B |
| IPO Year | 2017 | 2014 |
Fundamental Metrics
Financial Performance| Metric | DNLI | KEN |
|---|---|---|
| Price | $19.76 | $81.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $29.63 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 14.3K |
| Earning Date | 05-05-2026 | 03-30-2026 |
| Dividend Yield | N/A | ★ 5.90% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $188.54 | N/A |
| P/E Ratio | ★ N/A | $9.21 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.57 | $27.10 |
| 52 Week High | $23.77 | $87.60 |
Technical Indicators
Market Signals| Indicator | DNLI | KEN |
|---|---|---|
| Relative Strength Index (RSI) | 47.31 | 50.38 |
| Support Level | $18.56 | $77.45 |
| Resistance Level | $20.12 | $86.05 |
| Average True Range (ATR) | 1.14 | 2.21 |
| MACD | -0.00 | -0.60 |
| Stochastic Oscillator | 25.65 | 36.59 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About KEN Kenon Holdings Ltd.
Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.